Article
Alterations in late endocytic trafficking related to the pathobiology of LRRK2-linked Parkinson's disease.
Biochemical Society transactions - 1 Jun 2015
Rivero-Ríos Pilar, Gómez-Suaga Patricia, Fernández Belén, Madero-Pérez Jesús, Schwab Andrew J, Ebert Allison D, Hilfiker Sabine
Abstract excerpt
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene comprise the most common cause of familial Parkinson's disease (PD), and variants increase the risk for sporadic PD. LRRK2 displays kinase and GTPase activity, and altered catalytic activity correlates with neurotoxicity, making LRRK2 a promising therapeutic target. Despite the importance of LRRK2 for disease pathogenesis, its normal cellular function,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
